Bacteremia due to Methicillin-Resistant Staphylococcus aureus: New Therapeutic Approaches.


This article reviews recent clinical evidence for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia. Vancomycin remains the initial antibiotic of choice for the treatment of patients with MRSA bacteremia and endocarditis due to isolates with vancomycin minimum inhibitory concentration ≤2 μg/mL, whereas daptomycin is an effective… (More)
DOI: 10.1016/j.idc.2016.02.009


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics